awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q48301256-98A9AD1F-0D31-449F-B2FA-DAC93BCE881D
Q48301256-98A9AD1F-0D31-449F-B2FA-DAC93BCE881D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48301256-98A9AD1F-0D31-449F-B2FA-DAC93BCE881D
Pharmacokinetic Characterization and Dose Selection of a Novel Sumatriptan Nasal Spray Formulation, DFN-02.
P2860
Q48301256-98A9AD1F-0D31-449F-B2FA-DAC93BCE881D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48301256-98A9AD1F-0D31-449F-B2FA-DAC93BCE881D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
99ffa451d48accbdab27ccadf91f6fd4201ff1f0
P2860
A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of episodic migraine.